Reata Pharmaceuticals Inc

Invesco Ltd.

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

340,654

Value ($000)

34,733

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	34,733	0.0%	340,654	6/30/2023
2023 Q1	5/12/2023	36,691	0.0%	403,556	3/31/2023
2022 Q4	2/13/2023	3,423	0.0%	90,104	12/31/2022
2022 Q3	11/14/2022	681	0.0%	27,107	9/30/2022
2022 Q2	8/15/2022	814	0.0%	26,777	6/30/2022
2022 Q1	5/16/2022	1,839	0.0%	56,112	3/31/2022
2021 Q4	2/14/2022	60,134	0.0%	2,280,409	12/31/2021
2021 Q3	11/15/2021	345,978	0.1%	3,438,804	9/30/2021
2021 Q2	8/17/2021	397,659	0.1%	2,809,716	6/30/2021
2021 Q1	5/17/2021	205,019	0.1%	2,056,360	3/31/2021
2020 Q4	2/16/2021	219,979	0.1%	1,779,475	12/31/2020
2020 Q3	11/16/2020	54,812	0.0%	562,631	9/30/2020
2020 Q2	8/14/2020	8,297	0.0%	53,178	6/30/2020
2020 Q1	5/15/2020	231	0.0%	1,595	3/31/2020
2019 Q4	2/14/2020	10,618	0.0%	51,937	12/31/2019